Skip to main content
Haematologica logoLink to Haematologica
. 2023 Jun 15;108(9):2558. doi: 10.3324/haematol.2023.283685

Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model

Robin QH Kloos 1, Ron Mathôt 2, Rob Pieters 3, Inge M van der Sluis 1,3,
PMCID: PMC10483340  PMID: 37317924

With reference to our paper published in the May issue 2021 of Haematologica,1 we would like to draw your attention to Table 5 which contains two typing errors. In fact, in the column “Target trough levels: 100-250 IU/L”, the second “Week level” range should be 100-150 IU/L instead of 100-250 IU/L, while in the column “Target trough levels: 250-400 IU/L” the third “Week level” range should be 300-350 IU/L instead of 300-250 IU/L, as shown in the corrected Table 5 below.

Corrected Table 5.

Dosing guideline, dose adjustments.

graphic file with name 1082558.tab1.jpg

References

  • 1.Kloos RQH, Mathôt R, Pieters R, van der Sluis IM. Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model. Haematologica. 2021;106(5):1254-1261. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Haematologica are provided here courtesy of Ferrata Storti Foundation

RESOURCES